Harrow (HROW) Retained Earnings (2010 - 2026)
Harrow (HROW) recorded quarterly Retained Earnings of -$184.1 million in Q1 2026, down 17.63% quarter-over-quarter from -$156.5 million in Q4 2025, and down 8.84% on a YoY basis from -$202.0 million in Q1 2025.
Harrow (HROW) Retained Earnings (2010 - 2026) Analysis & Trends
Harrow's Retained Earnings history runs 17 years deep, the most recent figure standing at -$184.1 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 8.84% year-over-year to -$184.1 million; the TTM figure through Mar 2026 stood at -$184.1 million (down 8.84% YoY), while the FY2025 annual figure was -$156.5 million, down 3.39% from the prior year.
- Retained Earnings was -$184.1 million for Q1 2026 at Harrow, down from -$156.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$97.8 million in Q1 2022 to a low of -$184.1 million in Q1 2026.
- Historically, Retained Earnings has averaged -$139.1 million across 5 years, with a median of -$147.5 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings slumped 30.66% in 2022, then declined 3.15% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$109.5 million in 2022, then retreated by 22.29% to -$133.9 million in 2023, then declined by 13.05% to -$151.4 million in 2024, then slipped by 3.39% to -$156.5 million in 2025, then slipped by 17.63% to -$184.1 million in 2026.
- The last three Retained Earnings figures came in at -$184.1 million (Q1 2026), -$156.5 million (Q4 2025), and -$163.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | -184.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -184.13 Mn |
| Dec 31, 2025 | -156.52 Mn |
| Sep 30, 2025 | -163.15 Mn |
| Jun 30, 2025 | -164.17 Mn |
| Mar 31, 2025 | -169.17 Mn |
| Dec 31, 2024 | -151.39 Mn |
| Sep 30, 2024 | -158.16 Mn |
| Jun 30, 2024 | -153.94 Mn |
| Mar 31, 2024 | -147.47 Mn |
| Dec 31, 2023 | -133.90 Mn |
| Sep 30, 2023 | -124.76 Mn |
| Jun 30, 2023 | -120.37 Mn |
| Mar 31, 2023 | -116.14 Mn |
| Dec 31, 2022 | -109.49 Mn |
| Sep 30, 2022 | -110.55 Mn |
| Jun 30, 2022 | -104.08 Mn |
| Mar 31, 2022 | -97.85 Mn |
| Dec 31, 2021 | -95.41 Mn |
| Sep 30, 2021 | -87.99 Mn |
| Jun 30, 2021 | -79.66 Mn |